Horizon 2020 SME
News
August

Cracking the chest pain problem

FABPulous develops and markets pioneering solutions for better diagnostics in primary care and emergency medicine More than six out of 10 people referred for observation when complaining of

Read More

 

 

July

FABPulous wins €1.6m EU grant for clinical trials of 5 minute heart attack test

The European Union awarded FABPulous BV a €1.6 million Phase 2 grant to fund two clinical trials in the UK and Belgium/Netherlands and automate the manufacture of its

Read More

 

 

June

FABPulous BV Announces evolved Executive Management Team

Following successful completion of the €2.2m Series B funding round, FABPulous BV reorganises roles within an enlarged management team to meet the challenges of evolution from R&D start

Read More

 

 

June

Press Release – Successful Closure Series B Funding

FABPulous BV closes Series B Funding; Begins commercial activities with rapid 5-minute point-of-care IVD for myocardial infarction based on H-FABP February 4th 2015; Maastricht – Today FABPulous B.V.

Read More

 

 

April

FABPulous CEO Interview at Horizon 2020 launch in Brussels

FABPulous was delighted to be notified in December 2014 that it would be awarded an exceptional 100% contribution grant for €1.63m to fund clinical trials for use of

Read More